466 related articles for article (PubMed ID: 33189552)
1. Histogram Analysis of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson's Disease.
Zhang Y; Yang M; Wang F; Chen Y; Liu R; Zhang Z; Jiang Z
Acad Radiol; 2022 Mar; 29 Suppl 3():S71-S79. PubMed ID: 33189552
[TBL] [Abstract][Full Text] [Related]
2. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
3. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
Meng H; Zhang D; Sun Q
Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
[TBL] [Abstract][Full Text] [Related]
4. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
5. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
6. Histogram analysis of diffusion kurtosis imaging of deep brain nuclei in Parkinson's disease with different motor subtypes.
Wang J; Bi Q; Gong W; Zhang H; Deng M; Chen L; Wang B
Clin Radiol; 2023 Dec; 78(12):e966-e974. PubMed ID: 37838544
[TBL] [Abstract][Full Text] [Related]
7. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
[TBL] [Abstract][Full Text] [Related]
8. 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2
Li G; Zhai G; Zhao X; An H; Spincemaille P; Gillen KM; Ku Y; Wang Y; Huang D; Li J
Neuroimage; 2019 Mar; 188():465-472. PubMed ID: 30578927
[TBL] [Abstract][Full Text] [Related]
9. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
[TBL] [Abstract][Full Text] [Related]
11. Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
Jin J; Su D; Zhang J; Lam JST; Zhou J; Feng T
Chin Med J (Engl); 2024 May; ():. PubMed ID: 38809051
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
[TBL] [Abstract][Full Text] [Related]
14. Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping.
Fu X; Deng W; Cui X; Zhou X; Song W; Pan M; Chi X; Xu J; Jiang Y; Wang Q; Xu Y
Front Neurol; 2021; 12():631210. PubMed ID: 34421781
[TBL] [Abstract][Full Text] [Related]
15. Combining quantitative susceptibility mapping to radiomics in diagnosing Parkinson's disease and assessing cognitive impairment.
Kang JJ; Chen Y; Xu GD; Bao SL; Wang J; Ge M; Shen LH; Jia ZZ
Eur Radiol; 2022 Oct; 32(10):6992-7003. PubMed ID: 35461376
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
[TBL] [Abstract][Full Text] [Related]
17. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
19. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
Yan S; Lu J; Li Y; Cho J; Zhang S; Zhu W; Wang Y
Eur Radiol; 2024 May; 34(5):3074-3083. PubMed ID: 37853173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]